Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
<--- Back to Details
First Page
Document Content
Date: 2014-05-09 05:38:54
Brentuximab vedotin
CD30
Tumor antigen
Medicine
Monoclonal antibodies
Oncology
Add to Reading List
Source URL: www.biovaria.org
Download Document from Source Website
File Size: 561,76 KB
Share Document on Facebook
Similar Documents
Assessment RunCD30 Material The slide to be stained for CD30 comprised: 1-2. Tonsil, 3. Anaplastic large cell lymphoma (ALCL), 4. Embryonal carcinoma,
DocID: 1v5rE - View Document
3rd Meeting of the European Research Initiative on ALCL Punting on the River Cam with the chapel of King’s College in the background
DocID: 1n5ER - View Document
Assessment RunCD30 Recommended CD30 protocols Recommended CD30 control tissue
DocID: 1fsRl - View Document
BREAKOUT SESSION I ABSTRACT PRESENTATION 14 Brentuximab Vedotin in Patients With CD30+ Mesothelioma Mesothelioma, Thymic Malignancies and Other Thoracic Malignancies
DocID: 1cvRM - View Document
Journal of IMAB - Annual Proceeding (Scientific Papers) 2010, vol. 16, book 3 MODERN CLASSIFICATION OF CUTANEOUS PSEUDOLYMPHOMAS S. Shtilionova1, P.Drumeva1, M. Balabanova2, I. Krasnaliev3 1) Department of dermatology a
DocID: 15ISJ - View Document